{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:16:15Z","timestamp":1790817375768,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Phosphodiesterase type 5 inhibitors (PDE5i) are increasingly used beyond the treatment of erectile dysfunction, including for non-medical, performance-oriented purposes among men who have sex with men (MSM). This study aimed to systematically review the literature and meta-analyze the prevalence of recreational or non-medical PDE5i use among MSM and to explore potential sources of between-study heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis of observational studies was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. PubMed\/MEDLINE, Scopus, Cochrane Library, and Web of Science were searched from inception to March 2026. Studies reporting quantitative estimates of recreational, non-prescribed, or general PDE5i use among MSM were included. Pooled prevalence estimates were calculated using random-effects meta-analysis of proportions with logit transformation. Sensitivity analyses, subgroup analyses, and assessment of small-study effects using the Doi plot and Luis Furuya-Kanamori index were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five cross-sectional studies including 4390 MSM met the eligibility criteria. Reported prevalence ranged from 16.1% to 53.6%. The pooled prevalence of PDE5i use was 24.4% (95% CI, 16.7%-34.2%; I2\u00a0=\u200997.1%). Exclusion of the main outlier reduced the pooled estimate to 19.1% (95% CI, 17.0%-21.4%; I2\u00a0=\u200962.3%). Prevalence was higher in venue-based than community-based samples (32.4% vs. 19.9%) and in studies with a 6-month compared with a 3-month recall period (21.2% vs. 16.8%). The Luis Furuya-Kanamori index (2.43) suggested major asymmetry, consistent with possible small-study effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Recreational or non-medical PDE5i use appears common among MSM, affecting approximately one in four individuals overall and approximately one in five after exclusion of the main methodological outlier. Although this represents the first systematic review and meta-analysis addressing this topic, interpretation is limited by the small number of available studies, their cross-sectional design, reliance on convenience sampling, heterogeneous outcome definitions, and substantial between-study heterogeneity. These findings support routine clinical assessment of recreational PDE5i use among MSM, particularly in the context of concomitant illicit drug use, and highlight the need for standardized definitions and more robust epidemiological research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jsxmed\/qdag230","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:56:32Z","timestamp":1783684592000},"source":"Crossref","is-referenced-by-count":2,"title":["Beyond erectile dysfunction: recreational use of PDE5 inhibitors among men who have sex with men\u2014a systematic review and meta-analysis"],"prefix":"10.1093","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9359-7955","authenticated-orcid":false,"given":"Daniele","family":"Tienforti","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, Life Health and Environmental Sciences, Andrology Unit, University of L'Aquila , 67100 L'Aquila ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Moretto","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Life Health and Environmental Sciences, Andrology Unit, University of L'Aquila , 67100 L'Aquila ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Spagnolo","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Life Health and Environmental Sciences, Andrology Unit, University of L'Aquila , 67100 L'Aquila ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Ciriani","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Life Health and Environmental Sciences, Andrology Unit, University of L'Aquila , 67100 L'Aquila ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Cocci","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Life Health and Environmental Sciences, Andrology Unit, University of L'Aquila , 67100 L'Aquila ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Perfetto","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Life Health and Environmental Sciences, Andrology Unit, University of L'Aquila , 67100 L'Aquila ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Terrana","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Life Health and Environmental Sciences, Andrology Unit, University of L'Aquila , 67100 L'Aquila ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcangelo","family":"Barbonetti","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Life Health and Environmental Sciences, Andrology Unit, University of L'Aquila , 67100 L'Aquila ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Prunas","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Milan-Bicocca , 20126 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"2026073111314372900_ref1","doi-asserted-by":"publisher","first-page":"104398","DOI":"10.1016\/j.drugpo.2024.104398","article-title":"Exploring practices to enhance benefits and reduce risks of chemsex among gay, bisexual, and other men who have sex with men: a meta-ethnography","volume":"127","author":"Hawkinson","year":"2024","journal-title":"Int J Drug Policy"},{"issue":"5","key":"2026073111314372900_ref2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.2174\/1570159X15666161117151148","article-title":"When \"chems\" meet sex: a rising phenomenon called \"ChemSex\"","volume":"15","author":"Giorgetti","year":"2017","journal-title":"Curr Neuropharmacol"},{"issue":"10","key":"2026073111314372900_ref3","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.jsxm.2020.07.001","article-title":"Chemsex in Italy: experiences of men who have sex with men consuming illicit drugs to enhance and prolong their sexual activity","volume":"17","author":"Nimbi","year":"2020","journal-title":"J Sex Med"},{"key":"2026073111314372900_ref4","doi-asserted-by":"publisher","first-page":"108237","DOI":"10.1016\/j.drugalcdep.2020.108237","article-title":"Review of sexualized drug use associated with sexually transmitted and blood-borne infections in gay, bisexual and other men who have sex with men","volume":"216","author":"Guerra","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"2026073111314372900_ref5","doi-asserted-by":"publisher","first-page":"102943","DOI":"10.1016\/j.drugpo.2020.102943","article-title":"Pharmacosex: reimagining sex, drugs and enhancement","volume":"86","author":"Moyle","year":"2020","journal-title":"Int J Drug Policy"},{"key":"2026073111314372900_ref6","doi-asserted-by":"publisher","first-page":"1618070","DOI":"10.3389\/fpubh.2025.1618070","article-title":"Polydrug use during chemsex: single and intersecting sexual effects of commonly used drugs","volume":"13","author":"Platteau","year":"2025","journal-title":"Front Public Health"},{"issue":"10","key":"2026073111314372900_ref7","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1007\/s10461-025-04778-9","article-title":"High rates of drug use and chemsex among PrEP users and people with HIV in Milan highlight need for targeted interventions","volume":"29","author":"Fusetti","year":"2025","journal-title":"AIDS Behav"},{"issue":"3","key":"2026073111314372900_ref8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10508-010-9619-y","article-title":"Recreational use of erectile dysfunction medications in undergraduate men in the United States: characteristics and associated risk factors","volume":"40","author":"Harte","year":"2011","journal-title":"Arch Sex Behav"},{"issue":"5","key":"2026073111314372900_ref9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1590\/S0034-89102008000500024","article-title":"Use of phosphodiesterase-5 inhibitors by college students","volume":"42","author":"Freitas","year":"2008","journal-title":"Rev Saude Publica"},{"issue":"9","key":"2026073111314372900_ref10","doi-asserted-by":"publisher","first-page":"e13364","DOI":"10.1111\/and.13364","article-title":"Study of the prevalence and patterns of phosphodiesterase type 5 inhibitor use among sexually active Egyptian males: a national cross-sectional survey","volume":"51","author":"Attia","year":"2019","journal-title":"Andrologia"},{"key":"2026073111314372900_ref11","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"2026073111314372900_ref12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.15171\/ijhpm.2014.71","article-title":"The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence","volume":"3","author":"Munn","year":"2014","journal-title":"Int J Health Policy Manag"},{"issue":"3","key":"2026073111314372900_ref13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"7414","key":"2026073111314372900_ref14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"4","key":"2026073111314372900_ref15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","article-title":"A new improved graphical and quantitative method for detecting bias in meta-analysis","volume":"16","author":"Furuya-Kanamori","year":"2018","journal-title":"Int J Evid Based Healthc"},{"issue":"11","key":"2026073111314372900_ref16","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3109\/10826084.2015.1013135","article-title":"Significant misuse of sildenafil in London nightclubs","volume":"50","author":"Chan","year":"2015","journal-title":"Subst Use Misuse"},{"issue":"2","key":"2026073111314372900_ref17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/00126334-200306010-00012","article-title":"Viagra use in a community-recruited sample of men who have sex with men, San Francisco","volume":"33","author":"Chu","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"2026073111314372900_ref18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/sti.2004.010496","article-title":"Use of recreational Viagra among men having sex with men","volume":"80","author":"Crosby","year":"2004","journal-title":"Sex Transm Infect"},{"issue":"6","key":"2026073111314372900_ref19","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jsxm.2017.04.670","article-title":"Off-label use of phosphodiesterase type 5 inhibitor erectile dysfunction medication to enhance sex among gay and bisexual men in Australia: results from the FLUX study","volume":"14","author":"Hammoud","year":"2017","journal-title":"J Sex Med"},{"issue":"6","key":"2026073111314372900_ref20","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1136\/sti.2008.031476","article-title":"Motivations for the recreational use of erectile enhancing medications in urban gay and bisexual men","volume":"84","author":"Pantalone","year":"2008","journal-title":"Sex Transm Infect"},{"issue":"5B","key":"2026073111314372900_ref21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0002-9149(99)00114-9","article-title":"Cardiovascular effects of sildenafil citrate and recommendations for its use","volume":"84","author":"Kloner","year":"1999","journal-title":"Am J Cardiol"},{"issue":"11","key":"2026073111314372900_ref22","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1111\/j.1743-6109.2010.01965.x","article-title":"Recreational use of phosphodiesterase type 5 inhibitors by healthy young men","volume":"7","author":"Bechara","year":"2010","journal-title":"J Sex Med"},{"issue":"3","key":"2026073111314372900_ref23","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.sxmr.2021.10.004","article-title":"Recreational use of oral PDE5 inhibitors: the other side of midnight","volume":"10","author":"Mostafa","year":"2022","journal-title":"Sex Med Rev"},{"issue":"1","key":"2026073111314372900_ref24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1331\/1544345052843165","article-title":"Recreational use and misuse of phosphodiesterase 5 inhibitors","volume":"45","author":"Smith","year":"2005","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"2","key":"2026073111314372900_ref25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1742-1241.2009.02254.x","article-title":"Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database","volume":"64","author":"Giuliano","year":"2010","journal-title":"Int J Clin Pract"},{"key":"2026073111314372900_ref26","doi-asserted-by":"publisher","first-page":"101815","DOI":"10.1016\/j.legalmed.2020.101815","article-title":"Association between sexual activity-related death and non-prescription use of phosphodiesterase type 5 inhibitors","volume":"48","author":"Nagasawa","year":"2021","journal-title":"Leg Med (Tokyo)"},{"issue":"3","key":"2026073111314372900_ref27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/clc.4960250310","article-title":"Myocardial infarction following the combined recreational use of Viagra and cannabis","volume":"25","author":"McLeod","year":"2002","journal-title":"Clin Cardiol"},{"key":"2026073111314372900_ref28","doi-asserted-by":"publisher","first-page":"102504","DOI":"10.1016\/j.jflm.2023.102504","article-title":"Rare fatal effect of combined use of sildenafil and alcohol leading to cerebrovascular accident","volume":"95","author":"Pandit","year":"2023","journal-title":"J Forensic Leg Med"},{"issue":"2","key":"2026073111314372900_ref29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.23736\/S2724-6051.23.05611-2","article-title":"Major adverse cardiovascular events related to phosphodiesterase 5 inhibitors: analysis of real-life data from Eudra-vigilance database","volume":"76","author":"DE Nunzio","year":"2024","journal-title":"Minerva Urol Nephrol"},{"key":"2026073111314372900_ref30","doi-asserted-by":"publisher","first-page":"101593","DOI":"10.1016\/j.eucr.2021.101593","article-title":"Partial segmental thrombosis of the corpus cavernosum associated with recreational use of sildenafil","volume":"36","author":"Baaklini","year":"2021","journal-title":"Urol Case Rep"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/23\/8\/qdag230\/70385675\/qdag230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/23\/8\/qdag230\/70385675\/qdag230.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:31:47Z","timestamp":1785511907000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/doi\/10.1093\/jsxmed\/qdag230\/8747328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jsxmed\/qdag230","relation":{},"ISSN":["1743-6095","1743-6109"],"issn-type":[{"value":"1743-6095","type":"print"},{"value":"1743-6109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,7,3]]},"article-number":"qdag230"}}